Details of the Drug
General Information of Drug (ID: DMXKQFM)
| Drug Name |
5-Butyl-1H-pyrazole-3-carboxylic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
5-Butyl-1H-pyrazole-3-carboxylic acid; 92933-48-7; 5-Butyl-2H-pyrazole-3-carboxylic acid; 3-butyl-1H-pyrazole-5-carboxylic acid; CHEMBL428730; 890624-89-2; 3-butylpyrazole-5-carboxylic acid; 5-n-butyl-1H-pyrazole-3-carboxylic acid; BAS 13299640; AC1O5JK4; GTPL1591; SCHEMBL1527555; CTK8F6771; CTK6D6234; MolPort-027-640-734; ZJTXSGLJNBAMJS-UHFFFAOYSA-N; MolPort-002-026-457; ZX-AV000908; ZINC4386887; STL257894; BDBM50220842; BBL030719; 2213AF; SBB027985; AKOS024458395; 5-butyl-1H-pyrazol-3-carboxylic acid; AKOS000301963; CHM0075795
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 168.19 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References


